GPCR Symposium on 'GPCRs as Therapeutic Modalities' with Richa Tyagi, Dr. Terry Kenakin, Dr.

Growth hormone disorders, while scientifically rich, were relatively rare. the pancreatic islet — specifically the beta cells  that release insulin — offered a unique model: Rich

Assay Smarter Celtarys explores how fluorescent ligands enable safer, high-throughput screening with rich

present comparative MSM analyses of 150-μs simulations of opsin in cholesterol-free and cholesterol-rich

analysis of the N267K mutation in the fibronectin type III domain 1 (FnIII.1) suggest the cysteine-rich

C3aR localizes to the early phagosome during Hc infection where it coordinates the formation of actin-rich

Family B GPCRs have a rich history of allosteric ligands that produce activation.

271. https://doi.org/10.1007/s00232-020-00158-7 Gonçalves-Monteiro, S., Ribeiro-Oliveira, R., Vieira-Rocha https://doi.org/10.1111/tra.12649 Ribeiro-Oliveira, R., Vojtek, M., Gonçalves-Monteiro, S., Vieira-Rocha

comprising a Venus Flytrap (VFT) module linked to the seven transmembrane domains (TMDs) by a short cysteine-rich

extracellular Venus flytrap (VFT) unit that activates G protein-dependent signaling via twin Cysteine-rich

Contribute to an evolving field still rich with firsts.  

show that cholesterol interactions with the transmembrane domain TMD, unlike those with the cysteine-rich

A functional study of the leucine-rich repeat-containing (LGR2) gene in Hyphantria cunea (HLGR2) was

GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich

triggered the formation of cell condensations that developed aligned, anisotropic neotissue structures rich

But if you deconvolute into affinity and efficacy, a rich SAR emerges.

Hosted by the Adhesion GPCR Consortium, this exciting event will occur in lively and culturally rich

maintain an immunosuppressive tumor microenvironment, and facilitate metastatic spread (Nagarsheth, Wicha

Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1

it matters: Allosteric inhibitors often retain potency under high substrate conditions, such as ATP-rich

widely adopted approaches for measuring receptor activation, providing rapid, sensitive, and information-rich

identifies leads, and the structure-activity data obtained for the ensemble of candidate hits provides a rich